NextBioMedical Co Ltd
KOSDAQ:389650
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| KR |
N
|
NextBioMedical Co Ltd
KOSDAQ:389650
|
628.2B KRW |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
200.1B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
174.7B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
146.9B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
126.6B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.4B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.2B EUR |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
52.7B USD |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
49.9B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48B USD |
Loading...
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.3B USD |
Loading...
|
Market Distribution
| Min | -646.5% |
| 30th Percentile | 12.8% |
| Median | 19.7% |
| 70th Percentile | 32.2% |
| Max | 54 001.3% |
Other Profitability Ratios
NextBioMedical Co Ltd
Glance View
NextBioMedical Co Ltd is a KR-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Incheon, Incheon. The company went IPO on 2024-08-20. NextBioMedical Co Ltd is a Korea-based company mainly engaged in the manufacturing and sales of medical equipment. The firm is mainly engaged in the manufacturing and sales of medical equipment, such as endoscopic hemostatic agents and vascular embolic microspheres. In addition, the Company is also engaged in the research and development of medical equipment.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for NextBioMedical Co Ltd is 68.2%, which is above its 3-year median of 66.8%.
Over the last 5 months, NextBioMedical Co Ltd’s Gross Margin has increased from 65.3% to 68.2%. During this period, it reached a low of 65.3% on May 30, 2025 and a high of 68.2% on Oct 30, 2025.
